Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
-1.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
+$54B
(-5.6%)
Cap. Flow
-$972M
Cap. Flow
% of AUM
-1.8%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
985
New
115
Increased
314
Reduced
359
Closed
149
Top Buys
| 1 |
Hubbell
HUBB
|
$208M |
| 2 |
Norfolk Southern
NSC
|
$145M |
| 3 |
Insmed
INSM
|
$137M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$136M |
| 5 |
Soleno Therapeutics
SLNO
|
$116M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$355M |
| 2 |
Royalty Pharma
RPRX
|
$334M |
| 3 |
McDonald's
MCD
|
$198M |
| 4 |
Union Pacific
UNP
|
$188M |
| 5 |
HES
Hess
HES
|
$182M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
976
Norwegian Cruise Line
NCLH
$11.2B
| – | – | -410,800 | Closed | -$10.6M |
|
977
Annaly Capital Management
NLY
$13.6B
| – | – | -900,000 | Closed | -$16.5M |
|
978
NET Power Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
NPWR.WS
$44.1M
| – | – | -20,000 | Closed | -$72K |
|
979
NovoCure
NVCR
$1.38B
| – | – | -200,000 | Closed | -$5.96M |
|
980
Northwest Natural Holdings
NWN
$1.7B
| – | – | -241,242 | Closed | -$9.54M |
|
981
Olema Pharmaceuticals
OLMA
$375M
| – | – | -365,198 | Closed | -$2.13M |
|
982
Omnicom Group
OMC
$15.2B
| – | – | -31,410 | Closed | -$2.7M |
|
983
Oric Pharmaceuticals
ORIC
$994M
| – | – | -500,000 | Closed | -$4.04M |
|
984
UGI
UGI
$7.44B
| – | – | -425,000 | Closed | -$12M |
|